A Study of LY3435151 in Participants With Solid Tumors

J1Q-MC-JZIA -

The reason for this study is to see if the study drug LY3435151 is safe in participants with advanced solid tumors.

Trial Summary

Age Range
≥18 years
Conditions the trial is for
What the trial is testing?
Could I receive a Placebo?
No
Enrollment Goal
2
Trial Dates
Oct 28, 2019 - Mar 5, 2020
How long will I be in the trial?
Your participation in this trial could last up to 12 months or longer, depending on your cancer type and how you and your tumor respond.
Trial Phase
I

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.